Publications by authors named "G M Assanto"

Claim this Profile
M
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.
Roberta Soscia, Giovanni Manfredi Assanto, Irene Della Starza, Riccardo Moia, Donatella Talotta

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial.
Federico Ravaioli, Antonio Colecchia, Jacopo Peccatori, Daria Pagliara, Anna Grassi, Giovanni Manfredi Assanto

Bone Marrow Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study.
Giovanni Manfredi Assanto, Eleonora Alma, Alessandro Cellini, Giovanni Marsili, Gianluca Maiorana

Hemasphere· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients.
M Biglietto, S Ligia, A Laganà, G M Assanto, M Gherardini

Mediterr J Hematol Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Radiotherapy and Attenuated Chemotherapy Regimens in Older Patients with Classic Hodgkin Lymphoma: A Real-Life Study from the ReLLi Network.
Maria Christina Cox, Matteo Caridi, Alexandro Patirelis, Ilaria Del Giudice, Alessandro Pulsoni, Giovanni Manfredi Assanto

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis